OKYO Pharma Limited Change of Record Time and Last Day of Dealings (3356Z)
May 15 2023 - 2:00AM
UK Regulatory
TIDMOKYO
RNS Number : 3356Z
OKYO Pharma Limited
15 May 2023
OKYO Pharma Limited
("OKYO" or "Company")
Change of Record Time and Last Day of Dealings
London, May 15, 2023 - OKYO Pharma Limited (Nasdaq: OKYO; LSE:
OKYO) ("OKYO" or the "Company"), an ophthalmology-focused
bio-pharmaceutical company which is developing OK-101 to treat dry
eye disease ("DED") to address the significant unmet need in this
multi-billion-dollar market, previously announced a date of 12 May
2023 on which the cancellation of its ordinary shares of no par
value each ("Ordinary Shares") from listing on the standard segment
of the FCA's Official List and trading on the main market for
listed securities of the LSE ("Main Market") ("Delisting") were to
occur. The Delisting will now take place on Monday, 22 May 2023 to
facilitate late transfers of certificated positions into CREST
ahead of the Delisting.
As such, in keeping with the change of Delisting date, the
Company today announces a revised timetable of principal events
including a change to the record time and last day of dealings in
the existing Ordinary Shares on the Main Market. The revised
timetable is as follows:
Record Time close of business on 18 May 2023
Last day of dealings in the Existing Ordinary Shares on the Main Market 19 May 2023
---------------------------------------
Main Market Delisting 8.00 a.m. on 22 May 2023
---------------------------------------
ADR Facility Termination 8.00 a.m. on 22 May 2023
---------------------------------------
Share Capital Consolidation effective 8.00 a.m. on 22 May 2023
---------------------------------------
Date for filing of registration statement on Form F-1 which will, upon By 16 April 2023
effectiveness, give
such holders of New Ordinary Shares the ability to freely resell such
restricted securities
---------------------------------------
Date for crediting of the New Ordinary Shares in uncertificated to DTC 22 May 2023
members' accounts
---------------------------------------
Effectiveness of New Ordinary Shares Nasdaq Listing and commencement of 22 May 2023
trading in New Ordinary
Shares on Nasdaq
---------------------------------------
Date of dispatch of DR S statements in respect of the New Ordinary Shares in Within 10 Business Days of 22 May 2023
certificated
form
---------------------------------------
The securities to which the Delisting relates are the Ordinary
Shares of OKYO Pharma Limited with ISIN GG00BD3FV870. Following the
Delisting, it will no longer be possible to trade the Ordinary
Shares on the Main Market or any other market of the LSE.
Enquiries:
Gary S. Jacob,
OKYO Pharma Limited Chief Executive Officer +44 (0)20 7495 2379
Investor Relations Paul Spencer +44 (0)20 7495 2379
Optiva Securities
Limited
(Broker) Robert Emmet +44 (0)20 3981 4173
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCLZLFFXELLBBE
(END) Dow Jones Newswires
May 15, 2023 02:00 ET (06:00 GMT)
Okyo Pharma (LSE:OKYO)
Historical Stock Chart
From Sep 2024 to Oct 2024
Okyo Pharma (LSE:OKYO)
Historical Stock Chart
From Oct 2023 to Oct 2024